BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 10631132)

  • 1. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.
    Tassone F; Hagerman RJ; Taylor AK; Gane LW; Godfrey TE; Hagerman PJ
    Am J Hum Genet; 2000 Jan; 66(1):6-15. PubMed ID: 10631132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated FMR1 mRNA in premutation carriers is due to increased transcription.
    Tassone F; Beilina A; Carosi C; Albertosi S; Bagni C; Li L; Glover K; Bentley D; Hagerman PJ
    RNA; 2007 Apr; 13(4):555-62. PubMed ID: 17283214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.
    Tassone F; Hagerman RJ; Loesch DZ; Lachiewicz A; Taylor AK; Hagerman PJ
    Am J Med Genet; 2000 Sep; 94(3):232-6. PubMed ID: 10995510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
    Salat U; Bardoni B; Wöhrle D; Steinbach P
    J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.
    Primerano B; Tassone F; Hagerman RJ; Hagerman P; Amaldi F; Bagni C
    RNA; 2002 Dec; 8(12):1482-8. PubMed ID: 12515381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
    Kenneson A; Zhang F; Hagedorn CH; Warren ST
    Hum Mol Genet; 2001 Jul; 10(14):1449-54. PubMed ID: 11448936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male.
    Han XD; Powell BR; Phalin JL; Chehab FF
    Am J Med Genet A; 2006 Jul; 140(13):1463-71. PubMed ID: 16761284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
    García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
    RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of FMR1 transcript and protein levels among 74 premutation carriers.
    Peprah E; He W; Allen E; Oliver T; Boyne A; Sherman SL
    J Hum Genet; 2010 Jan; 55(1):66-8. PubMed ID: 19927162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neural activity in the 'when' pathway during temporal processing in fragile X premutation carriers.
    Kim SY; Tassone F; Simon TJ; Rivera SM
    Behav Brain Res; 2014 Mar; 261():240-8. PubMed ID: 24398265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered neural activity of magnitude estimation processing in adults with the fragile X premutation.
    Kim SY; Hashimoto R; Tassone F; Simon TJ; Rivera SM
    J Psychiatr Res; 2013 Dec; 47(12):1909-16. PubMed ID: 24045061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.
    Hessl D; Tassone F; Loesch DZ; Berry-Kravis E; Leehey MA; Gane LW; Barbato I; Rice C; Gould E; Hall DA; Grigsby J; Wegelin JA; Harris S; Lewin F; Weinberg D; Hagerman PJ; Hagerman RJ
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):115-21. PubMed ID: 16184602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of AGG interruptions in the transcription of FMR1 premutation alleles.
    Yrigollen CM; Tassone F; Durbin-Johnson B; Tassone F
    PLoS One; 2011; 6(7):e21728. PubMed ID: 21818263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral protein synthesis in a knockin mouse model of the fragile X premutation.
    Qin M; Huang T; Liu Z; Kader M; Burlin T; Xia Z; Zeidler Z; Hukema RK; Smith CB
    ASN Neuro; 2014; 6(5):. PubMed ID: 25290064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.